Amdal CD, Falk RS, Alanya A, Schlichting M, Roychoudhury S, Bhatnagar V, Wintner LM, Regnault A, Ingelgård A, Coens C, le Cessie S, Holzner B, Chang J, Taphoorn M, Cislo P, Giesinger JM, Cappelleri JC, Pawar V, Ten Seldam S, Papadopoulos EJ, Calvert MJ, Joseph KL, Bottomley A, Griebsch I, Arraras JIet al.(2025) SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials Lancet Oncol, 26(12), e683-e693 DOI 10.1016/S1470-2045(25)00520-0, PubMed 41308689
Romero-Becerra R, Zhao Z, Nebdal D, Müller E, Bergholtz H, Norum JH, Aittokallio T(2025) Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool Nat Commun, 16(1), 10151 DOI 10.1038/s41467-025-65218-9, PubMed 41258298
Taskén K, Mahon P(2025) Accelerating precision oncology by converging pragmatic trials and real-world evidence Nat Rev Drug Discov, 24(11), 809-810 DOI 10.1038/d41573-025-00047-5, PubMed 40082591
